Howard Hughes Medical Institute.
Cancer Cell. 2010 Nov 16;18(5):510-23. doi: 10.1016/j.ccr.2010.10.012.
We investigated whether melanoma is hierarchically organized into phenotypically distinct subpopulations of tumorigenic and nontumorigenic cells or whether most melanoma cells retain tumorigenic capacity, irrespective of their phenotype. We found 28% of single melanoma cells obtained directly from patients formed tumors in NOD/SCID IL2Rγ(null) mice. All stage II, III, and IV melanomas obtained directly from patients had common tumorigenic cells. All tumorigenic cells appeared to have unlimited tumorigenic capacity on serial transplantation. We were unable to find any large subpopulation of melanoma cells that lacked tumorigenic potential. None of 22 heterogeneously expressed markers, including CD271 and ABCB5, enriched tumorigenic cells. Some melanomas metastasized in mice, irrespective of whether they arose from CD271(-) or CD271(+) cells. Many markers appeared to be reversibly expressed by tumorigenic melanoma cells.
我们研究了黑色素瘤是否呈等级组织,存在具有肿瘤发生和非肿瘤发生表型的不同亚群的细胞,还是大多数黑色素瘤细胞保留了肿瘤发生能力,而与其表型无关。我们发现,直接从患者获得的 28%的单个黑色素瘤细胞在 NOD/SCID IL2Rγ(null)小鼠中形成肿瘤。直接从患者获得的所有 II 期、III 期和 IV 期黑色素瘤均具有共同的肿瘤发生细胞。所有肿瘤发生细胞似乎在连续移植中具有无限的肿瘤发生能力。我们无法找到任何缺乏肿瘤发生潜力的大黑色素瘤细胞亚群。包括 CD271 和 ABCB5 在内的 22 种异质表达标记物均未富集肿瘤发生细胞。一些黑色素瘤在小鼠中转移,无论它们是否来自 CD271(-)或 CD271(+)细胞。许多标记物似乎可被肿瘤发生的黑色素瘤细胞可逆性表达。